It fits right into Walmart's small store expansion. Perfect fit into their new business model.
Damn yo sound like there is already trouser chili running down your legs lol
Walmart is adding stores just the size of Rite Aids. Rite Aid comes with the pharmacy built in. Also at what time would a company say they were interested and watch the price rise too fast.
WMT because it fits exactly into their new business model of small groceries in convenient areas with the plus of having their Pharmacy outlets expanded as well.
Sep. 17, 2014 2:28 PM ET | About: Rite Aid Corporation (RAD)
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
•The whisper number is $0.06, in-line with the analysts' estimate.
•Rite Aid has a 48% positive surprise history (having topped the whisper in 22 of the 46 earnings reports for which we have data).
•The overall average price move is 'as expected' (beat the whisper number and see strength, miss and see weakness) when the company reports earnings.
Rite Aid (NYSE:RAD) is expected to report earnings on Thursday, September 18th. The whisper number is $0.06, in-line with the analysts' estimate and showing neutral confidence from the WhisperNumber community. Whispers range from a low of $0.05 to a high of $0.08. Rite Aid has a 48% positive surprise history (having topped the whisper in 22 of the 46 earnings reports for which we have data).
- Beat whisper: 22 qtrs
- Met whisper: 1 qtrs
- Missed whisper: 23 qtrs
Our primary focus is on post earnings price movement. Knowing how likely a stock's price will move following an earnings report can help you determine the best action to take (long or short). In other words, we analyze what happens when the company beats or misses the whisper number expectation.
The table below indicates the average post earnings price movement within a one and thirty trading day time frame:
(click to enlarge)
The strongest price movement of +7.7% comes within thirty trading days when the company reports earnings that beat the whisper number, and -7.7% within ten trading days when the company reports earnings that miss the whisper number. The overall average price move is 'as expected' (beat the whisper number and see strength, miss and see weakness) when the company reports earnings.
The table below indicates the most recent earni
It really doesn't matter if it breaks 6.60 or not today as all focus will be on earnings tomorrow.
actually I set a window on BING with RAD Rite Aid and put it on news and Most Recent. It updates by itself.
Rite Aid's (NYSE: RAD ) stock price has dropped more than 20% since the company lowered its earnings guidance in early June. This has made the pharmacy chain one of Wall Street's most volatile stocks this year.
With the company on tap to update investors on its fiscal second-quarter results Thursday, here are three points to keep in mind before rushing to buy or sell Rite Aid's shares.
1. Generic bugaboo
Rite Aid had high hopes when it inked a deal that turned over its generic drug purchasing and distribution to McKesson. However, delays in getting the deal up to speed weighed heavily on the company's fiscal first quarter, forcing Rite Aid to cut its full-year earnings guidance to $0.30-$0.40 per share.
Clearly, off-loading costly inventory and distribution could prove friendly to Rite Aid's bottom line, but management's stumble in predicting when those benefits could be realized has kept investors cautious. Investors would be wise to look for any updated guidance from management on how the program is progressing.
2. Clinics, clinics, clinics
Rite Aid's decision earlier this year to buy RediClinic could give it plenty of opportunity to play catch up to CVS Health and Walgreen in providing convenient, low-cost healthcare services to customers in their stores. Both of its rivals have a massive head start, so Rite Aid won't catch up to them anytime soon. But if the company is going to turn the corner from boosting profit by cost-cutting to boosting profit from growth, it will need to ramp up programs like RediClinic.
Last quarter, Rite Aid announced plans to open 18 RediClinic locations over the next 18 months, at a cost of roughly $200,000 per location. While all eyes will be focused on Rite Aid's full-year profit guidance in the upcoming quarterly report, investors should also watch whether the RediClinic plans have changed. After all, it wouldn't be encouraging to see Rite Aid reduce the number of planned RediClinic launches in order to m
"I base this on rads 30 year 8.00 average share price for the last 30 years."
That is absolutely meaningless.
There was no problem with a simple copy and paste. At times there is a problem when they contain links. I take links out because YaHoo more times than not will not accept the post with links.
You are obviously wrong. Should be doing this now...that now. Earnings, The Fed and Options Market Maker are affecting the stock. You should wait til after earnings rather than appearing as Trouser Chili is running down your leg.
Rite Aid Corporation's Strong Showing
Sep. 15, 2014 1:02 PM ET | 5 comments | About: Rite Aid Corporation (RAD), Includes: MCK
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
•Rite Aid Corporation reported strong results for the month of August and Q2 2014.
•Rite Aid has launched several programs that have helped revenues swell over the past few quarters. The company has launched the Wellness+ program to strengthen its relationship with its customers.
•In February, Rite Aid announced a distribution agreement with McKesson. Based on this collaboration, the company anticipated to make cost savings, which are taking longer than expected to materialize.
•Some investors are wary of the collaboration with McKesson because the company doesn’t seem to be benefiting from the cost savings that were anticipated from this collaboration.
•Even if the cost savings are not in sight during this quarter or the next one, the agreement will ultimately bear fruit for the company in the long run.
Rite Aid Corporation (NYSE:RAD) reported strong results for the month of August and Q2 2014. The company's comparable store sales reported an increase of 3.9% till 30 August 2014. This was due to an improvement in comparable sales of the front-end and pharmacy, with these stores showing a higher prescription count. Comparable pharmacy sales were also up by 5.2% for the month of August.
Total drugstore sales for August have increased by 3.7% relative to the sales last year. Sales for the month of August stood at $2.515 billion, while they amounted to $4.425 billion last year. 69.3% of total drugstore sales were contributed by prescription sales whereas the third party prescription sales accounted for almost 97.5% of pharmacy sales.
Second Quarter Results
The second quarter, which ended on 30th August 2014, reported a rise in comparable sales of 4.1%. This rise was co
You can bet the pennystock P&D trolls ill be actively predicting their crazy targets. Thursday is the important day. Not fluctuations in daily price that are generally based on -0- analysis and maximum nonsense.
Q2 2015 Rite Aid Corp Earnings Release $0.061 $0.05 to $0.073 52.50%
You scared of something? Seems like you are panicking for the longs. ROFLMAO. They don't need your dice.